- Home
- ACLS vs WGS Comparison
ACLS vs WGS Comparison
Compare ACLS & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACLS
- WGS
- Stock Information
- Founded
- ACLS 1995
- WGS 2017
- Country
- ACLS United States
- WGS United States
- Employees
- ACLS N/A
- WGS N/A
- Industry
- ACLS Industrial Machinery/Components
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- ACLS Technology
- WGS Technology
- Exchange
- ACLS Nasdaq
- WGS Nasdaq
- Market Cap
- ACLS 2.2B
- WGS 2.4B
- IPO Year
- ACLS 2000
- WGS N/A
- Fundamental
- Price
- ACLS $80.04
- WGS $129.49
- Analyst Decision
- ACLS Buy
- WGS Strong Buy
- Analyst Count
- ACLS 5
- WGS 7
- Target Price
- ACLS $90.00
- WGS $99.29
- AVG Volume (30 Days)
- ACLS 563.4K
- WGS 728.8K
- Earning Date
- ACLS 08-05-2025
- WGS 10-28-2025
- Dividend Yield
- ACLS N/A
- WGS N/A
- EPS Growth
- ACLS N/A
- WGS N/A
- EPS
- ACLS 4.91
- WGS 0.05
- Revenue
- ACLS $896,089,000.00
- WGS $362,321,000.00
- Revenue This Year
- ACLS N/A
- WGS $35.84
- Revenue Next Year
- ACLS $5.27
- WGS $18.46
- P/E Ratio
- ACLS $16.31
- WGS $2,645.63
- Revenue Growth
- ACLS N/A
- WGS 48.70
- 52 Week Low
- ACLS $40.40
- WGS $28.86
- 52 Week High
- ACLS $113.37
- WGS $130.91
- Technical
- Relative Strength Index (RSI)
- ACLS 54.35
- WGS 69.85
- Support Level
- ACLS $79.78
- WGS $114.25
- Resistance Level
- ACLS $82.77
- WGS $130.33
- Average True Range (ATR)
- ACLS 2.71
- WGS 5.82
- MACD
- ACLS -0.26
- WGS -0.14
- Stochastic Oscillator
- ACLS 30.19
- WGS 93.05
About ACLS Axcelis Technologies Inc.
Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.